Catalogue products are positioned with a purity specification of 95% or higher. Values such as 99% should be displayed only when supported by the lot-specific report.
Chromatographic purity documentation supports release review and reseller documentation packs.
Mass confirmation helps verify that reported material aligns with the expected peptide identity.
Third-party laboratory review is positioned as a core trust layer for professional reseller channels.
Cleanroom-style visuals support the website's medical and professional tone while communicating process control and laboratory discipline.
Purity and identity statements are framed around supporting records, not generic marketing language.
Every label and product page should point to the correct lot documentation before distribution.
Pages avoid therapeutic claims, dosing, patient-facing use, or consumer purchase language.
Manufactured lots are tied to internal batch references and release-supporting records.
Manufactured lot is assigned internal SKU, batch, and traceability references.
HPLC and MS records are collected for purity and identity review.
Independent reports are matched to lot details before documentation release.
COA, chromatogram, mass confirmation, and third-party results are organized for reseller review.
